January 28, 2008
Biotech industry group launches company for low cost medications
A New Haven-based organization that represents Connecticut's biotech industry is turning its talents to developing low-cost medications for poor countries.
Connecticut United for Research Excellence, also known as CURE, has spun off a nonprofit company, Developing World Cures Inc.
It plans to develop low-cost pharmaceuticals for people in the world's poorest countries.
The president of CURE says the plan is to produce drugs that for-profit companies have found too risky as investments, while also developing Connecticut's biotechnology industry.
Modeled after California's Institute for OneWorld Health, World Cures would focus on treatments for diseases such as malaria, river fever, heartworm, hookworm and tuberculosis.
WBJ Web Partners
Most Recent
Most Recent
0 Comments